AI assistant
JOHNSON & JOHNSON — Director's Dealing 2024
Feb 15, 2024
29750_dirs_2024-02-15_557244b2-431d-4c96-9642-eee0ed201099.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-13
Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-13 | Common Stock | M | 499.0000 | $0.0000 | Acquired | 13290.0000 | Direct |
| 2024-02-13 | Common Stock | F | 250.0000 | $157.8500 | Disposed | 13040.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-13 | Restricted Share Units | $ | M | 499.0000 | Disposed | Common Stock (499.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 700.0000 | Indirect |
| Common Stock | 46.0000 | Indirect |
Footnotes
F1: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting.
F2: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3: Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).